HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy.

Abstract
Secondary pulmonary alveolar proteinosis (PAP) is one of the complications of hematologic malignancy and immunosuppressive diseases. We encountered four cases of myelodysplastic syndrome (MDS) associated with PAP detected on autopsy. They consisted of two refractory anemia (RA) and two patients with refractory anemia with excess blasts in transformation (RAEBt) at the time of MDS diagnosis, but all of them developed leukemic phase and were resistant to chemotherapy at the time of pulmonary episodes. Of the four MDS patients, two also had pulmonary aspergillosis. Previously, 69 patients with PAP associated with hematologic disorders have been reported, but there have been only seven cases with MDS, including our four patients. Of the 69 reported cases of PAP in hematologic malignancies, 24/63 (38%) informative patients with infection had fungal infections of the lung; 2/7 (29%) MDS cases had fungal infection. We should, therefore, pay careful attention to this possibility in cases of MDS with lung complications, including PAP, especially in patients in the leukemic phase of MDS.
AuthorsNahoko Shoji, Yoshikazu Ito, Yukihiko Kimura, Jiroh Nishimaki, Yuzuru Kuriyama, Tetsuzo Tauchi, Makoto Yaguchi, Dilnur Payzulla, Yoshiro Ebihara, Kazuma Ohyashiki
JournalLeukemia research (Leuk Res) Vol. 26 Issue 6 Pg. 591-5 (Jun 2002) ISSN: 0145-2126 [Print] England
PMID12007507 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Aged
  • Autopsy
  • Fatal Outcome
  • Female
  • Humans
  • Lung Diseases, Fungal (pathology)
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes (complications)
  • Pulmonary Alveolar Proteinosis (etiology, microbiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: